Isbn: 9783319765921 - drug adherence in hypertension and cardiovascular protection (updates in hypertension and cardiovascular protection) (4 Ergebnisse)

ISBN
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (4)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: Springer, 2018

    3319765922 / 9783319765921

    Serie: Buch 4 von 14 - Updates in Hypertension and Cardiovascular Protection

    • Hardcover
    • Erstausgabe

    Anbieter: Antique Emporium, Eau Claire, WI, USAAntique Emporium

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Gut bis sehr gut

    EUR 35,83

    EUR 4,79 Versand 
    Versand innerhalb von USA

    Anzahl: 1 verfügbar

    Hardcover. Zustand: Near Fine. No Jacket. 1st Edition. Hardcover book in near fine condition.

  • Sprache: Englisch

    Verlag: Springer, 2018

    3319765922 / 9783319765921

    Serie: Buch 4 von 14 - Updates in Hypertension and Cardiovascular Protection

    • Hardcover

    Anbieter: Anybook.com, Lincoln, Vereinigtes KönigreichAnybook.com

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Befriedigend

    EUR 34,83

    EUR 15,86 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 1 verfügbar

    Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,800grams, ISBN:9783319765921.

  • Sprache: Englisch

    Verlag: Springer, 2018

    3319765922 / 9783319765921

    Serie: Buch 4 von 14 - Updates in Hypertension and Cardiovascular Protection

    • Hardcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 186,13

    EUR 14,58 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Hardcover. Zustand: Brand New. 314 pages. 9.25x6.10x0.87 inches. In Stock.

  • Sprache: Englisch

    Verlag: Springer, 2018

    3319765922 / 9783319765921

    Serie: Buch 4 von 14 - Updates in Hypertension and Cardiovascular Protection

    • Hardcover

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 180,92

    EUR 30,50 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient's adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of several interventions aimed at improving drug adherence and put particular emphasis on the importance of an interdisciplinary approach involving nurses and pharmacists. The volume also includes a careful analysis of the health and economic impact of poor adherence.The book is aimed at physicians, pharmacists, students and all health professionals dealing not only with hypertension or dyslipidemia, but also with chronic asymptomatic diseases such as diabetes, HIV or chronic respiratory diseases.